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Abstract: In both Drosophila and mammalian systems, the Hippo (Hpo) signalling 
pathway controls tissue growth by inhibiting cell proliferation and promoting apoptosis. 
The core pathway consists of a protein kinase Hpo (MST1/2 in mammals) that is regulated 
by a number of upstream inputs including Drosophila Ras Association Factor, dRASSF. 
We have previously shown in the developing Drosophila eye epithelium that loss of the 
apico-basal cell polarity regulator lethal-(2)-giant-larvae (lgl), and the concomitant 
increase in aPKC activity, results in ectopic proliferation and suppression of developmental 
cell death by blocking Hpo pathway signalling. Here, we further explore how Lgl/aPKC 
interacts with the Hpo pathway. Deregulation of the Hpo pathway by Lgl depletion is 
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associated with the mislocalization of Hpo and dRASSF. We demonstrate that Lgl/aPKC 
regulate the Hpo pathway independently of upstream inputs from Fat/Dachs and the 
Kibra/Expanded/Merlin complex. We show depletion of Lgl also results in accumulation 
and mislocalization of components of the dSTRIPAK complex, a major phosphatase 
complex that directly binds to dRASSF and represses Hpo activity. However, depleting 
dSTRIPAK components, or removal of dRASSF did not rescue the lgl
−/−
 or aPKC 
overexpression phenotypes. Thus, Lgl/aPKC regulate Hpo activity by a novel mechanism, 
independently of dRASSF and dSTRIPAK. Surprisingly, removal of dRASSF in tissue with 
increased aPKC activity results in mild tissue overgrowth, indicating that in this context 
dRASSF acts as a tumor suppressor. This effect was independent of the Hpo and Ras 
Mitogen Activated Protein Kinase (MAPK) pathways, suggesting that dRASSF regulates a 
novel pathway to control tissue growth. 




The Hpo pathway is conserved from flies to humans and plays a central role in development and 
disease. Hpo signalling controls organ size by coordinately promoting apoptosis and blocking cell 
proliferation (reviewed [1]). The core of the Hpo pathway is composed of two kinases: Hpo 
(orthologue of mammalian sterile 20-like kinase-1 and -2, MST1 and MST2) and Warts (Wts) 
(orthologue of human large tumor suppressor, LATS1 and LATS2). Hpo and Wts are found in a 
complex with the scaffolding proteins Salvador (Sav, an orthologue of human WW45) and Mob as 
tumor suppressor (MATS). Through various upstream pathways, such as the atypical cadherin Fat 
and/or the FERM domain-containing proteins Expanded (Ex) and Merlin (Mer) in association with 
Kibra, Hpo senses membrane associated signals and activates Wts through phosphorylation. Upon 
activation, Wts phosphorylates and inhibits Yorkie (Yki, an orthologue of human Yes-Associated 
Protein, YAP), a transcriptional coactivator that binds to transcription factors such as Scalloped 
(orthologue of human Tea Domain proteins, TEAD1-4) and activates expression of cell survival (e.g., 
diap1, Drosophila inhibitor of apoptosis-1) and cell proliferation (e.g., cyclin E) genes, as well as 
feedback pathway targets, expanded (ex) and four-jointed (fj). 
The mammalian Ras Association domain family (RASSF) contains ten different members that fall 
into two groups, classical (RASSF1-6) and N-terminal (RASSF7-10) proteins (reviewed [2,3]).  
The defining feature of all RASSF proteins is a Ras association domain (RA) that can be found  
C-terminally (RASSF1-6) or N-terminally (RASSF7-10). RASSF proteins 1-6 also encode a SARAH 
protein-protein interaction domain (also present in Salvador, RASSF, Hippo). In Drosophila, there is a 
single, classical RASSF gene, dRASSF. Similar to its mammalian homologues (RASSF1-6) dRASSF 
encodes a C-terminal Ras Association and SARAH domain. In dRASSF, the SARAH domain mediates 
dimerization with Hpo and regulates tissue growth via the Hpo tumor suppressor pathway [4]. 
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dRASSF competes with Sav for Hpo binding via the SARAH domain. In doing so, dRASSF 
inactivates the Hpo kinase cascade, thereby increasing Yki activity and promoting tissue growth [4]. 
Recent studies in Drosophila have identified a phosphatase complex, dSTRIPAK (Drosophila  
Striatin-interacting phophatase and kinase) that directly binds dRASSF, dephosphorylates Hpo and 
restricts the activity of the pathway to promote tissue growth [5]. Thus, Hpo activity is regulated by a 
variety of inputs from the cell membrane, and more directly via association with dRASSF and the 
dSTRIPAK complex. 
It has long been recognized that loss-of-function mutations in the Drosophila apico-basal cell 
polarity gene lethal-giant-larvae (lgl) result in tissue overgrowth and neoplastic tumors [6]. We have 
shown in the developing Drosophila eye that loss of lgl and the concomitant increase in aPKC activity 
results in ectopic cell proliferation and suppression of developmental cell death (apoptosis) via 
impairment of the Hpo pathway, as assessed by decreased phospho-Yki and increased expression of 
target genes (cycE Diap1, ex and fj). Furthermore, when Yki levels were reduced in lgl
−/−
 tissue 
ectopic expression of Hpo pathway targets were normalized and overgrowth was decreased, showing that 
Yki activation was rate-limiting for the tissue overgrowth phenotype conferred by Lgl depletion [7].  
We also observed that Lgl/aPKC activity regulates the localization of Hpo/dRASSF [7]. Here we 
further dissect the relationship between Lgl/aPKC and Hpo pathway regulation. We show that 
Lgl/aPKC regulate the Hpo pathway independently of upstream components Fat and Kibra/Ex/Mer, 
the dSTRIPAK complex and dRASSF. Furthermore, dRASSF in the context of increased aPKC 
activity appears to have a tumor suppressor function.  
2. Experimental 
2.1. Fly Culture, Overexpression, and Clonal Analysis 
Mitotic eye clones and mosaic analysis with a repressible marker (MARCM) clones were generated 
as previously described [8]. Clonal and MARCM crosses were raised at 25 °C. Overexpression crosses 
with GMR > aPKC
CAAXWT
 were undertaken at 18 °C. 
2.2. Fly Stocks 
fat
fd
/CyO (Kieran Harvey, Peter MacCallum Cancer Centre, Melbourne, Australia); GMR-GAL4 
(Bloomington Stock Centre, Bloomington, IN, USA); UAS-aPKC
CAAXWT
 (Sonsoles Campuzano, 









/TM6B (Hugo Stocker, 





(Kenneth Irvine, The State University of New Jersey, New Brusnwick NJ, USA); diap1-GFP1.8 
(Duojia Pan, Johns Hopkins University School of Medicine, Baltimore, MD, USA); diap1-lacZ 
reporter, th
ic58
 (Bruce Hay, California Institute of Technology, Pasadena, CA, USA); actin < CD2 < GAL4, 
UAS-GFP (Bruce Edgar, Fred Hutchinson Cancer Research Center, Seattle, WA, USA); eyFLP; UAS-RFP, 
tubgal4, FRT82B, tubgal80/TM6B (Virender Sahota, Peter MacCallum Cancer Centre, Melbourne, 
Australia) this study; merlin (mer)-RNAi
14228R−1
 (National Institute of Genetics (NIG), Shizuoka , Japan); 














Drosophila RNAi Centre (VDRC), Vienna, Austria). 
2.3. Immunohistochemistry, Imaging and Antibodies 
Larval and pupal discs were dissected and fixed as previously described [7]. For Hpo, dRASSF, 
Cka and Mob4 staining, tissues were fixed in paraformaldehyde lysine periodate (PLP). Labeled 
samples were cleared through 80% glycerol and mounted. For Figure 1, Figure 2E, Figure 3A,C, 
Appendix Figure A1B,C, and Figure 4A,B images were collected on Biorad MRC1000 (Bio-Rad 
Laboratories, Hercules, CA, USA). Figure 2B, Figure 3B and Appendix Figure A1A were collected on 
an Olympus FV1000 (Olympus, Center Valley, PA, USA). Images in Figure 2C,D and Figure 4G–I were 
taken on a Nikon Eclipse 90i (Nikon, New York, NY, USA). Images were processed using Fiji, and 
assembled with Adobe Photoshop CS6 and Adobe Illustrator CS6. Adult eyes were imaged with a Scitec 
Infinity1 camera (Lumenera, Ottawa, Canada). 
Antibodies used were mouse anti-β-galactosidase (Sigma, St. Louis, MO, USA, 1:500), rat anti-Hpo 
(1:100), rabbit anti-dRASSF (1:200) both from Nicholas Tapon, Cancer Research, UK, rabbit anti-Cka 
(Wei Du, University of Chicago, Chicago, IL, USA 1:1000) rabbit anti-Lgl (Dennis Strand, Johannes 
Gutenberg University, Germany. 1:1000), guinea-pig anti-Mob4 (Joost Schulte, University of British 
Columbia, Vancouver, Canada, 1:1000), rat anti-Shg (E-cadherin, Developmental Studies Hybridoma 
Bank, DSHB, University of Iowa, IA, USA. 1:50), rabbit anti-aPKC (Santa Cruz Biotechnology, 
Dallas, TX, USA, human PKCζ 1:500). 
2.4. Quantification of Interommatidial Cell (IOC) Number 
The number of IOCs (secondary and tertiary pigment cells) for a single ommatidium was quantified 
by drawing a hexagon connecting the centers of the six surrounding neighboring ommatidia. IOCs 
within the hexagon were then counted. IOCs that straddled the boundary were counted as half a cell. 
2.5. Quantification of Adult Eye Size  
The perimeter of adult eyes was outlined in Photoshop CS3 and the total area in pixels calculated. 
Data was analysed using unpaired t-test (Welch corrected). 
2.6. Statistical Analysis of Signal Intensity 
To determine the relative diap1-GFP1.8 expression in eye discs, images of each disc were taken 
with identical confocal settings. Using Image J, a ratio of average pixel intensity was determined for 
diap1-GFP1.8 immunofluorescence in an area posterior and anterior to the morphogenetic furrow that 
colocalized with DAPI staining. Data was analyzed using unpaired t-test (Welch corrected). 
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Figure 1. lgl regulates the Hippo (Hpo) pathway in parallel with fat and merlin. (A–G) Mosaic 
mid-pupal retinae stained with Drosophila E-cadherin (DE-Cad) antibodies that localize to the 
adherens junction and mark cell outlines. (A–E) mutant tissue lacks the expression of green 
fluorescent protein (GFP) and is merged with DE-Cad expression in (A'–E'). (A) Control, 
wildtype retina containing mosaic tissue expressing GFP and GFP negative tissue, white 
arrowheads denote photoreceptor and cone cells, yellow arrowheads denote IOCs; (B) Retina 
with fat
−/−
 tissue or (E) lgl
−/−
 tissue. The mutant area (GFP negative) shows a few extra IOC’s 
(yellow arrowheads); (C) hpo
−/−
 clone (GFP negative); (D) lgl, fat
−/−
 double mutant tissue (GFP 
negative) displays a substantial increase in IOC number (yellow arrowheads); (F) mer-RNAi 
depleted tissue (marked by the presence of GFP) shows a few additional IOC’s (yellow 
arrowheads); (G) lgl
−/−
; mer-RNAi tissue (marked by the presence of GFP) display excess 
IOC’s (yellow arrowheads); (H) Mean number of IOCs per ommatidia. **** indicates  
p < 0.0001. Error bars represent Standard Deviation. n equals the number of ommatidia 
counted; (I–L) Adult male eye images; (I) Control, mosaic eye; (J) mer−/−, mosaic eye (mer−/− 
tissue is pale red); (K) lgl
−/−
 mosaic eye (lgl
−/−
 tissue is white); (L) mer; lgl double mutant 
mosaic eye (note the decrease in adult retinal tissue (white arrowhead) and increase in head 
capsule tissue (yellow arrowhead).  
  
(A) Control: eyFLP; FRT40/UbiGFP, FRT40; (B) fat: eyFLP; fatfd, FRT40/UbiGFP, FRT40; (C) hpo: eyFLP, FRT42D, 
hpo5.1/FRT42D, UbiGFP; (D) lgl, fat: eyFLP, lgl27S3, fatfd, FRT40/UbiGFP, FRT40; (E) lgl: eyFLP, lgl27S3, FRT40/UbiGFP, FRT40; 
(F) mer-i: eyFLP, UAS-GFP; FRT40/tubgal80, FRT40; UAS mer-RNAi14228R/tubgal4; (G) lgl;mer-i: eyFLP, UAS-GFP; lgl27S3, 
FRT40/gal80, FRT40; UAS-mer-RNAi14228R/tubgal4; (I) Control: eyFLP; FRT40/UbiGFP FRT40; (J) mer: y w Mer4 
FRT19A/Y; FRT40A/P[w+ Mer+], Ubi-GFP, FRT40A; eyGAL4, UAS-flp/+; (K) lgl: eyFLP; lgl27S3, FRT40/UbiGFP, FRT40; 
(L) mer; lgl: y w Mer4 FRT19A/Y; P[w+ Mer+] Ubi-GFP FRT40A/lgl27S3 FRT40A; eyGAL4, UAS-flp/+. 
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Figure 2. lgl regulates the Hpo pathway independently of Fat-Dachs and Kibra/Expanded/Merlin branches. (A) Western Blot showing Wts protein 
levels; (B, C, E) Planar sections of larval eye discs; (D) Sideview of larval eye disc. White scale bar represents 50 µM. Yellow bar denotes the 
morphogenetic furrow (MF), posterior is to the left in planar sections, in this and all other figures; (F–K) Adult female eye images; (L) Graphical 
representation of adult eye size presented in (F–K); (A) Western Blot analysis of protein extracts derived from control and Lgl depleted larval  












 tissue identified by lack of Lgl antibody staining (green); (C,C',D,D') Hpo (white) and (E,E') dRASSF (white) staining in 
kibra, mer-RNAi mosaic eye discs. In kibra, mer-RNAi tissue (RFP positive, green, mutant tissue indicated by arrowheads) Hpo and dRASSF 
concentration and localization are normal compared to wildtype tissue (RFP negative); (C"–E") Overlay of RFP and antibody staining, pink 





 mosaic adult eyes; (F) Control adult eye; (G) GMR > aPKC
CA
 adult eye; (H) kibra
−/−





 shows synergistic increase in adult eye size; (J) lgl
−/−
 mosaic adult eye (lgl
−/−





adult eye (double mutant tissue is white, arrowhead denotes head cuticle tissue); (L) Quantification of adult eye size (F–K).  
 
(A) Control: eyFLP; actin < CD2 < GAL4; UAS-GFP; lgli: eyFLP; actin < CD2 < GAL4; UAS-GFP/UAS-lgl-RNAi51247; (B) dachs1: lgl, dachsGC13: eyFLP; lgl27S3, dachsGC13, FRT40/dachs1, 
FRT40; diap1-lacZ reporter (thic58)/+; (C–E) kibra, mer-i: eyFLP; FRT82B, kibra4, UAS-merlin RNAi14228R−1/UAS-mRFP, tubgal4, FRT82B, tubgal80; (F) Control: GMR-GAL4/+; (G) GMR > 
aPKCCA: GMR-GAL4 > UAS-aPKCCAAXWT/+; (H) kibra: eyFLP; FRT82B, kibra1/FRT82B, P{w+} cell lethal; (I) GMR > aPKCCA; kibra: eyFLP; GMR-GAL4 > UAS-aPKCCAAXWT/+; FRT82B, 
kibra1/FRT82B, P{w+} cell lethal; (J) lgl: eyFLP; lgl27S3, FRT40/Ubi-GFP, FRT40; (K) lgl, kibra: eyFLP; lgl27S3, FRT40/Ubi-GFP, FRT40; FRT82B, kibra1/FRT82B, P{w+} cell lethal; (L) 
Mean eye size represented by the area * indicates p < 0.05; **** indicates p < 0.0001. Error bars represent Standard Deviation. n = 12 eyes per genotype. 
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Figure 3. Members of the dSTRIPAK complex are mislocalized in lgl
−/−
 tissue and 
genetically interact with GMR>aPKC
CA
. (A, C, H, I) Planar sections of larval eye discs; 
(B) Cross section of larval eye disc. Yellow line indicates morphogenetic furrow. White 
scale bar represents 50 µM; (A, A', A''') lgl
−/−
 mosaic eye disc stained for Cka (white) and 
Hpo (white) respectively. Mutant clones display apical accumulation of Hpo and Cka 
(arrowheads); (B, B') lgl
−/−
 mosaic eye disc, stained for Cka (white) displays apical 
accumulation and basolateral mislocalization of Cka (mutant tissue GFP negative, white 
arrowheads indicate Cka mislocalization); (B''') Green dots outline GFP clone boundaries; 
(C, C', C''') lgl
−/−
 mosaic eye disc, stained for Mob4 (white) and Hpo (white) respectively. 
Only moderate accumulation of Mob4 was observed compared to Hpo (mutant tissue GFP 
negative, arrowheads indicate Mob4 mislocalization); (A"–C") Overlay of GFP and 
antibody staining, pink highlights wildtype GFP positive tissue; (D–G) Adult female eye 
images of GMR > aPKC
CA
 and depletion of dSTRIPAK components; (D) CTTNBP2;  
(E) CCM3i; (F) ckai; (G) mob4. Reducing the levels of mob4, but not other dSTRIPAK 
components, in conjunction with GMR > aPKC
CA
 alters tissue growth.  
 
(A–C) lgl: eyFLP; lgl27S3, FRT40/UbiGFP, FRT40; (D) GMR > aPKCCA/CTTNBP2: GMR-GAL4 > UAS-
aPKCCAAXWT/UAS-CTTNBP2-RNAi31377; (E) GMR > aPKCCA/CCM3i: GMR-GAL4 > UAS-aPKCCAAXWT/ 
UAS-CCM3-RNAi106841; (F) GMR > aPKCCA/ckai: GMR-GAL4 > UAS-aPKCCAAXWT/UAS-cka-RNAi106971; (G) 
GMR > aPKCCA/mob4i: GMR-GAL4 > UAS-aPKCCAAXWT/UAS-mob4-RNAi11074. 
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Figure 4. Hpo mislocalization in lgl
−/−
 mosiac tissue is independent of dRASSF and dRASSF acts as a tumor suppressor. (A, G–I) Planar sections of 
larval eye discs; (B) Cross section of larval eye disc. Yellow line indicates morphogenetic furrow. White scale bar represents 50 µM. (C–E) Adult 
female eye images. (A) lgl; dRASSF double mutant tissue (GFP negative) displays apical accumulation of Hpo (white, arrowhead indicates double 
mutant, GFP negative tissue) compared to dRASSF mutant tissue (GFP positive) and is mislocalized basolaterally in lgl; dRASSF double mutant 
tissue (B arrowhead). aPKC staining (white) is altered where the tissue shows obvious folds (A, white asterik) but is still localized apically in lgl; 
dRASSF double mutant tissue (B); (C, C', D, D', E, E') Adult female eye images, side and ventral views respectively; (C,C') dRASSF; (D, D') lgl; 
dRASSF; (E, E') GMR > aPKC
CA
, dRASSF. The eye size of lgl mosaic and GMR > aPKC
CA
 overexpressing adult eyes is increased when dRASSF is 
removed; (F) Western blot of protein extracts from eye discs detecting pERK, total ERK and tubulin levels; (F') Graphical representation of signal 
intensity from Western blots. There is a two fold increase in pERK/ERK levels in GMR > aPKC
CA
 mutant tissue. However, removal of dRASSF 
does not alter the relative ratio of pERK/ERK in either a wildtype or GMR > aPKC
CA
 tissue; (G–H) dRASSF, GMR > aPKCCA, GMR > aPKCCA; 
dRASSF crossed with diap1-GFP1.8. GFP expression (green) reports diap1 expression. Compared with the control; (G) dRASSF; (H) GMR > 
aPKC
CA
; and (I) GMR > aPKC
CA
; dRASSF discs show elevated levels of diap1-GFP1.8 expression but there is no increase in diap1-GFP1.8 
expression between GMR > aPKC
CA
 and GMR > aPKC
CA
; dRASSF tissue; (J) Graph of the ratio of intensity from posterior versus anterior regions 
of diap1-GFP1.8 expressing samples, taken from apical section. The upregulation of diap1-GFP1.8 in GMR > aPKC
CA
 and GMR > aPKC
CA
; 
dRASSF tissue is significant compared to dRASSF alone but there is no significant difference between GMR > aPKC
CA
 and GMR > aPKC
CA
; 
dRASSF tissues. n = 5 discs per sample. Error bars represent Standard Error of the Mean. ** indicates p < 0.001.  
 
(A,B) lgl; dRASSF: eyFLP; lgl27S3, FRT40/UbiGFP, FRT40; dRASSFX36/X36; (C) Control dRASSF: dRASSFX36/X36; (D) lgl; dRASSF: eyFLP; lgl27S3, FRT40/UbiGFP, FRT40; dRASSFX36/X36; (E)  
GMR > aPKCCA; dRASSF: GMR-GAL4 > UAS-aPKCCAAXWT; dRASSFX36/X36; (F) Control: w1118, dRASSF: dRASSFX36/X36, GMR>aPKCCA: GMR-GAL4 > UAS-aPKCCAAXWT GMR > aPKCCA; dRASSF, GMR-GAL4 > UAS-
aPKCCAAXWT; dRASSFX36/X36; (G) Control dRASSF: GMR-GAL4 > diap1-GFP1.8/+; dRASSF X36/X36; (H) GMR > aPKCCA: GMR-GAL4 > diap1-GFP1.8/UAS-aPKCCAAXWT; (I) GMR > aPKCCA; dRASSF: GMR-GAL4 > diap1-
GFP1.8/UAS-aPKCCAAXWT; dRASSF X36/X36. 
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2.7. Sample Preparation and Western Blot Analysis 
Eye-antennal discs were dissected from w1118, dRASSF
X36/X36
, GMR > aPKC
CAAXWT





 or ey-FLP and eyFLP; lgli actin-FLP-out larvae, homogenized in 0.1 M 
Tris-HCl pH 6.8, 2% SDS. 5 mM EDTA, 5 mM DTT buffer containing Complete protease inhibitor 
cocktail (Roche, Basel, Switzerland), 1 mM Na3(VO)4, 5 mM NaF2. In Figure 2A, protein 
concentration was determined by Lowry assays. Samples containing 20 mg of protein were 
electrophoresed on a 10% SDS-PAGE gel and transferred to Immobilon-FL polyvinylidene difluoride 
membranes. In Figure 4F, 11 eye disc pairs were dissected per sample and electrophoresed as above. 
Antibodies used in Figure 2A were rabbit anti-Lgl (Dennis Strand, Johannes Gutenberg University, 
Germany. 1:1000), rabbit anti-Wts (Kenneth Irvine, The State University of New Jersey, NJ, USA. 
1:500) and mouse anti-actin (Developmental Studies Hybridoma Bank, DSHB, University of Iowa, IA, 
USA. 1:100) and in Figure 4F were mouse anti-pERK (Sigma, St. Louis, MO, USA., 1:10,000), anti 
rabbit-ERK 137 F5 (Cell Signalling, Danvers, MA, USA 1:1000) and mouse anti-α-tubulin 
(Calbiochem, MERCK, Darmstadt, Germany 1:10,000). The signal intensity of bands in Figures 2A 
and 4F was measured in Fiji and relative pERK/ERK levels were normalized to α-tubulin. 
3. Results 
3.1. lgl Regulates the Hpo Pathway Independently of Fat and Dachs 
To determine how Lgl regulates the Hpo pathway we asked if loss of lgl function affected the 
phenotypes of known upstream regulators of the Hpo pathway. First, we assessed if Lgl genetically 
interacted with the atypical cadherin Fat [9–11]. A defining characteristic of Hpo pathway mutants is 
an increase in cell number in the pupal retina [12]. The Drosophila eye develops from the eye imaginal 
disc, a single-cell-layered epithelial sheet that grows during larval stages. After photoreceptor and cone 
cells are determined, interommatidial cells (IOC’s) are specified to become pigment cells, with excess 
IOC’s are eliminated by apoptosis. Interommatidial (or pigment cells) surround the centrally located 
photoreceptor and cone cells, generating a precise, repeating hexagonal structure (ommatidium), which 
can be visualized during the pupal stage (Figure 1A; white arrowheads mark photoreceptor, cone and 
primary pigment cells, yellow arrowheads indicate secondary and tertiary pigment cells). In mutants 
such as hpo
−/−
, where developmental cell death is inhibited, IOC’s accumulate between the ommatidia 
of the pupal retina (Figure 1C; yellow arrowhead). lgl
−/−
 tissue also fails to undergo programmed cell 
death and a few extra cells can be observed in lgl
−/−
 retinae (Figure 1E; yellow arrowhead), however 
this phenotype is not as strong as that displayed by hpo
−/−





 tissue showed only a few extra cells (Figure 1B yellow arrowhead). Notably, lgl, 
fat double mutant tissue showed a greater number of IOC’s than either lgl or fat single mutant retinae 
(compare Figure 1D with Figure 1B,E). Quantification of the number of IOC’s per ommatidia in fat or 
lgl single mutants revealed an average of two or eight additional cells respectively. Strikingly the 
average number of IOC’s per ommatidia in lgl, fat double mutant tissue was thritythree (quantified in 
Figure 1H). This data shows that lgl and fat act synergistically to regulate IOC number during eye 
development, and therefore might function redundantly within the same pathway or in parallel pathways. 
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We then wished to determine if Lgl and Fat acted together within the same complex or 
independently of each other to regulate Hpo signalling. Therefore we analyzed if Wts protein levels 
were reduced in lgl
−/−
 tissue. Fat regulates the Hpo pathway, in part by regulating the stability of Wts 
kinase. Wts protein levels are reduced in fat
−/−
 tissue and this decrease in Wts is dependent on the 
activity of an unconventional myosin, Dachs [13,14]. In fat, dachs double mutant tissue, the loss of 
dachs restores Wts protein levels, thereby increasing the levels of phospho-Yki and downregulating 
target gene expression [13]. 
We previously used the ey-FLP-actin-FLP-out system combined with a lgl-RNAi transgene to 
specifically knockdown Lgl and showed that when Lgl is depleted in the eye-antennal imaginal disc 
phospho-Yki levels decrease and Yki target gene expression is increased [7]. When Lgl was knocked 
down by 80% using ey-FLP-actin-FLP-out (Figure 2A), Western blot analysis showed that there was 
no statistically significant change (unpaired t-test Welch’s correction, p > 0.05, n = 4) in Wts protein 
levels between control eye-antennal tissue and lgl-RNAi depleted tissue (Figure 2A). This data shows 
that lgl does not mediate Hpo pathway activation by decreasing Wts protein levels.  
We have shown that lgl
−/−
 tissue upregulated the diap1 transcriptional reporter diap1-lacZ [7]. To 
test the requirement of dachs in this phenotype, we investigated whether removing dachs would reduce 
the elevated level of diap1-lacZ expression in lgl
−/−
 tissue to wildtype. dachs
GC13/GC13
 clones grow 
poorly when surrounded by wildtype tissue [14], therefore we generated lgl, dachs
GC13/GC13
 clones in a 
dachs
1
 background. This enabled us to recover lgl, dachs
GC13/GC13
 clones in larval eye discs, however 
lgl, dachs
GC13/GC13
 clones were not observed in adult eyes (data not shown). We found that in lgl, 
dachs
GC13/GC13
 tissue upregulation of diap1-lacZ persisted (arrowheads Figure 2B–B'''). Thus, 
activation of Yki target genes upon depletion of Lgl is independent of dachs function. 
Taken together, the synergistic effects on increased cell number observed in lgl, fat double mutant 
pupal retinas, maintenance of elevated diap1-lacZ gene expression in lgl, dachs double mutant tissue, 
and the lack of change in Wts protein levels in lgl-RNAi depleted eye-antennal discs, strongly supports 
the notion that lgl acts separately and in parallel with Fat/Dachs to regulate the Hpo pathway. 
3.2. lgl Regulates the Hpo Pathway Independently of the Apical Kibra/Expanded/Merlin Complex 
The discovery of the apical FERM domain containing complex Kibra/Expanded/Merlin (KEM) as a 
regulator of Hpo signalling [15–17], and that in mammalian systems, Kibra has been shown to be a 
direct target of aPKC phosphorylation [18], raised the possibility that lgl may regulate Hpo pathway 
activity via the KEM complex. 
Initially we investigated tissue growth phenotypes of lgl
−/−
; ex-RNAi or lgl
−/−
; mer-RNAi depleted 
larval eye discs. lgl
−/−
; ex-RNAi or lgl
−/−
; mer-RNAi depleted larval eye discs showed excess tissue 
growth, greater than single mutants alone, and these animals mostly failed to pupate (data not shown). 
In one lgl
−/−
, mer-RNAi depleted pupal disc that we were able to recover, we observed a significant 
increase in IOC’s, (compare Figure 1E–G), similar to that observed for lgl, fat double mutants 
(compare Figure 1D,G). Consistent with the breakdown of tissue observed in the lgl
−/−
;mer-RNAi 
pupal retina (Figure 1G), rare adult male escapers double mutant for mer and lgl showed a dramatic 
loss of differentiated adult eye tissue (white arrowhead) and an increase in head capsule tissue (yellow 
arrowhead, compare Figure 1I–L). The increase in IOC’s in lgl−/−; mer-RNAi retina and increased 
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tissue growth of lgl
−/−
; ex-RNAi larval eye discs shows that Lgl and the KEM complex act synergistically 
which might indicate that they act redundantly in the same pathway or in parallel pathways to regulate 
the Hpo pathway. 
In our analysis of the effect of Lgl depletion/aPKC activation on the localization of Hpo pathway 
components, we observed co-mislocalization of Hpo and dRASSF, and proposed that Lgl/aPKC 
regulate the Hpo pathway through Hpo/dRASSF apical localization [7]. To determine if components of 
the KEM complex and Lgl regulate the Hpo pathway via redundant or independent mechanisms we 
investigated whether the localization of Hpo and dRASSF was altered by depletion of the KEM 
complex. As members of the KEM complex are functionally redundant with one another we chose to 
undertake these studies in a stronger double mutant background of kibra
−/−
, mer-RNAi (the efficacy of 
the mer-RNAi is demonstrated in Figure 1G and discussed above). We have previously shown that Hpo 
and dRASSF proteins accumulate apically and are mislocalized basolaterally in lgl
−/−
 tissue [7], 
(demonstrated here again in Figure 3A,C, showing apical accumulation of Hpo in lgl
−/−
 tissue). In 
contrast, in kibra
−/−
, mer-RNAi tissue, Hpo and dRASSF showed normal apical levels (Figure 2C,D, 
RFP positive tissue, arrowheads). Furthermore, a sideview of a kibra
−/−
, mer-RNAi eye disc (Figure 2D) 
showed no basolateral mislocalization of Hpo. Thus, kibra and merlin activity do not regulate the 
localization of Hpo and dRASSF. 
To further investigate the genetic interaction between lgl and kibra, we generated adult eyes 
comprised entirely of kibra mutant tissue and asked what happened to tissue growth if we generated lgl 
mutant tissue, or overexpressed a constitutively membrane-bound (active) version of aPKC 
(aPKC
CAAXWT
 hereafter referred to as aPKC
CA




 adult eyes 




 alone (compare Figure 2H,J,K). This is 
particularly noticeable in head capsule tissue that shows excessive tissue growth (Figure 2K, 
arrowheads). As previously reported [17], adult eyes comprised of entirely kibra
−/−
 tissue showed a 
weak increase in eye size (3%) when compared with control eyes (compare Figure 2F,H, quantified in 
Figure 2L). GMR > aPKC
CA
 adult eyes showed a 12% increase in eye size compared with control eyes 
(compare Figure 2F,G, quantified in Figure 2L). Consistent with the phenotype of adult eyes double 





) have a synergistic increase in eye size (38% compared to control eyes), greater than 
kibra
−/−
 or GMR > aPKC
CA
 alone (Figure 2I, quantified in Figure 2L). Taken together, the normal 
levels and localization of Hpo and dRASSF in kibra
−/−
, mer-RNAi tissue, and genetic interaction data 
showing that kibra
−/−




 overexpression to 
regulate tissue growth, supports the notion that Lgl/aPKC regulate the Hpo pathway independently of 
the apical KEM complex. 
3.3. Members of the dSTRIPAK Complex Are Mislocalized in lgl Mutant Tissue 
The discovery of a PP2A phosphatase complex, dSTRIPAK, which exclusively interacts with 
dRASSF/Hpo and not Hpo/Sav [5], raised the possibility that Lgl/aPKC regulates the Hpo pathway by 
modulating dSTRIPAK activity. In human cells, PP2A complex formation is achieved through the 
combinatorial assembly of two PP2A catalytic subunits, a regulatory B subunit and two scaffolding 
subunits (reviewed [19]). The dSTRIPAK complex associated with Hpo also contains two catalytic 
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subunits, a regulatory subunit Cka (Connector of kinase to AP-1) and a kinase Mob4 (Mps one binder 
kinase activator-like 4). We used immunohistochemistry to determine, if similar to Hpo and dRASSF, 
Cka and Mob4 are mislocalized in lgl
−/−
 tissue. In the developing Drosophila larval eye disc, Hpo, Cka 
and Mob4 localized apically and associated with cell membranes to outline the developing ommatidial 
clusters (Figure 3A,C). Like Hpo, in lgl
−/−
 tissue, Cka accumulated apically compared with the 
surrounding wildtype tissue (Figure 3A arrowheads). Cross section of the eye disc revealed that in 
lgl
−/−
 clones posterior to the morphogenetic furrow there was apical accumulation and basolateral 
mislocalization of Cka (Figure 3B, lgl
−/−
 tissue denoted by arrowheads). The change in Cka 
localization in lgl
−/−
 tissue is independent of changes in apico-basal cell polarity, because we have 
previously shown that cell polarity is maintained in lgl
−/−
 larval eye disc clones [7]. Mob4 and Hpo 
staining partially overlapped in lgl
−/−
 tissue. Although there were some regions of the eye disc that showed 
some accumulation of Mob4 (Figure 3C, arrowhead) Mob4 was less affected than Hpo (Figure 3C 
arrowhead). Taken together, these results show that Lgl is required for the correct localization of 
dRASSF and Hpo, and members of the phosphatase dSTRIPAK complex, Cka and Mob4. 
We predicted that mislocalization of negative regulators of the Hpo pathway such as dRASSF and 
members of the dSTRIPAK complex, lead to the observed decrease in Hpo pathway activity and the 
subsequent upregulation of Yki pathway targets in lgl
−/−
 tissue. Therefore, reduction of negative 
regulators of the Hpo pathway, such as dSTRIPAK [5], might restore Hpo signalling and reduce tissue 
growth. We used the GMR > aPKC
CA
 phenotype, which shows mislocalization of Hpo proteins, 
upregulation of Hpo pathway targets and a weak adult eye overgrowth phenotype (Figure 2G, 
quantified 2L), to determine if depletion of dSTRIPAK complex members could suppress aPKC 
mediated Hpo pathway activity. To achieve this, we depleted each dSTRIPAK member (CCM3 
(CG5073), SLMAP (CG17494), CTTNBP2 (CG10915), FAM40A (CG11526), FGOP2 (CG10158), cka 
and mob4) using RNAi in the developing Drosophila eye via the GMR driver. Knockdown of 
dSTRIPAK members alone via the GMR driver produced no observable effects. However, as  
predicted [5], all RNAi’s enhanced the GMR-GAL4, UAS-hpo phenotype at 18 °C and were late pupal 
lethal displaying severe eye and head defects (data not shown). Moreover, examination of GMR-GAL4 
induced knockdown of Cka at 18 °C, or in clones at 18 °C, revealed a significant depletion of  
apically-localized Cka protein (compare Cka staining in control disc to cka-RNAi depleted disc 
Supplementary Figure 1A,B, arrowheads and in clones 1C). However, when tested for their interaction 
with GMR > aPKC
CA
, none of the dSTRIPAK complex component depletions suppressed the GMR > 
aPKC
CA
 phenotype (Figure 3D–F; and data not shown). Conversely, mob4 depletion in conjunction 
with GMR > aPKC
CA
, resulted in a slight increase in adult eye size and an accumulation of glassy 
tissue in the posterior region of the adult eye (Figure 3G) relative to GMR > aPKC
CA
 alone. These data 
show that only one dSTRIPAK complex member, Mob4, showed a genetic interaction with Lgl/aPKC. 
However, this interaction is opposite to what would be expected if dSTRIPAK is responsible for the 
decreased Hpo activity in aPKC
CA
 over-expressing tissue. Thus, depletion of the dSTRIPAK complex 
components does not reduce tissue growth in GMR > aPKC
CA
 adult eye, and therefore the dSTRIPAK 
complex is not a critical factor in the impairment of Hpo activity by activated aPKC. 
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3.4. lgl Mutant Tissue Mislocalizes and Inactivates Hpo Pathway Signalling Independently of  
dRASSF Function 
Previous studies have shown that Hpo and dRASSF form a protein complex that antagonizes Hpo 
pathway activity [3]. We wished to determine if dRASSF was required to mislocalize Hpo proteins in 
lgl
−/−
 tissue. To achieve this, we generated dRASSF homozygous mutant animals that also contained 
mosaic lgl
−/−
 tissue in the developing eye and examined Hpo localization. Hpo proteins still 




 tissue (Figure 4A arrowheads) and in cross sections of the 
developing eye disc, Hpo was clearly mislocalized basolaterally (arrowheads Figure 4B). The 
basolateral changes were not associated with cell polarity changes in lgl
−/−
 tissue because aPKC 
localization remains unchanged (Figure 4B). These data show that although Hpo and dRASSF directly 
bind to each other, this interaction is not required for the localization of Hpo in either dRASSF single 
mutant, or lgl; dRASSF double mutant tissue. 
3.5. dRASSF Acts as a Tumor Suppressor in lgl Mutant and GMR>aPKC
CA
 Tissue  
As stated previously, we predicted that mislocalization of negative regulators of the Hpo pathway, 
such as dRASSF, led to the observed upregulation of Hpo pathway targets in lgl
−/−
 tissue. Therefore, 
reduction in dRASSF activity might restore Hpo signalling and reduce tissue growth in lgl
−/−
 or  
GMR>aPKC
CA





 and dRASSF. Adult eyes from homozygous dRASSF single mutants develop and 
differentiate normally, but showed slightly reduced adult eye size consistent with an overall decrease 
in body size [4], (Figure 4C,C'). When dRASSF activity was removed in lgl
−/−
 mosaic or GMR > aPKC
CA
 
animals the resulting adult eyes were larger and showed tissue folds, consistent with increased tissue 
growth (Figure 4D,D',E,E' respectively). These data were opposite to that expected if dRASSF was 
acting to restrict Hpo function in lgl
−/−
 or GMR > aPKC
CA
 eyes, and instead demonstrate that dRASSF 
is required to restrict growth when aPKC activity is increased. These data suggest that dRASSF may 
act a tumor suppressor in this context.  
We predicted that loss of dRASSF would restore Hpo pathway signalling and decrease Yki target 
gene expression in GMR > aPKC
CA
 tissue. Therefore, we determined if Hpo pathway activation was 
suppressed and Yki target gene expression decreased by determining the levels of diap1-GFP reporter 
gene expression, (diap1-GFP1.8, which contains enhancer regions critical for the activation of diap1 
expression by Yki [20]). GMR > aPKC
CA




 eye discs show upregulation of 
diap1-GFP1.8 reporter gene expression (compare Figure 4G–J) when compared to control dRASSF single 
mutant eye discs (quantified in Figure 4J) but there was no statistically significant change of diap1-GFP1.8 
reporter gene expression between GMR > aPKC
CA




 eye discs (Figure 
4H,I, quantified in 4J) indicating that Yki target gene expression remains elevated in these eye discs. 
This result indicates that Yki target gene expression remains elevated when dRASSF function is 
depleted in GMR > aPKC
CA
 eye discs. This supports the observation that tissue growth was not 




 adult eyes and demonstrates that increased aPKC activity can 
lead to the activation of Yki target gene expression independently of dRASSF.  
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In mammalian systems classical RASSF proteins, such as RASSF5A/Nore1A, are known effectors 
of Ras signalling [21–23]. In Drosophila, loss of dRASSF is able to rescue growth defects in Ras 
mutant tissue [4], suggesting that dRASSF may be a negative regulator of Ras signalling. Activated 
Ras leads to increased phosphorylation of MAPK (ERK) therefore, we isolated protein extracts from 
larval eye discs mutant for dRASSF alone, expressing GMR > aPKC
CA





 tissue and determined the ratio of pERK versus total ERK levels by western blot analysis. 
As shown in Figure 4F, and quantified in Figure 4F', although a two fold increase in the relative ratio 
of pERK/ERK was detected in GMR > aPKC
CA
 discs compared to control wildtype eye discs, the 
removal of dRASSF had no effect on the ratio of pERK/ERK. This result demonstrates that MAPK 
signalling is not changed in dRASSF
−/−





4. Discussion and Conclusions 
Here we demonstrate that the apico-basal cell polarity regulators Lgl/aPKC regulate the Hpo 
pathway independently of upstream inputs Fat/Dachs and the Kibra/Ex/Mer complex. We also show 
that in addition to Hpo and dRASSF, members of the dSTRIPAK complex Cka and Mob4 are 
mislocalized in lgl
−/−
 tissue. We predicted that comislocalization of Hpo and dRASSF observed in 
lgl
−/−
 tissue, or eye discs overexpressing aPKC
CA
, was critical for deregulation of the Hpo pathway 
and upregulation of Yki target genes such as diap1 and cycE. However, we found that dRASSF was not 
required for Hpo mislocalization. Surprisingly, removal of dRASSF in lgl
−/−
 tissue, or eye discs 
overexpressing aPKC
CA
, did not suppress tissue overgrowth phenotypes, or reduce diap1 levels as 
predicted, but resulted in increased tissue growth. Moreover, knockdown of dSTRIPAK components 
did not rescue the eye overgrowth defects due to overexpression of aPKC
CA
. These data suggest that 
dRASSF or dSTRIPAK are not required for inhibition of Hpo by aPKC upregulation, and therefore 
Lgl/aPKC regulates the Hpo pathway by a novel mechanism (Figure 5).  
Previous studies in Drosophila, have proposed that dRASSF antagonizes Hpo pathway activity by 
directly competing with Sav for binding to the SARAH domain within Hpo [4]. In addition, dRASSF 
forms a multimeric protein complex with Hpo and a phosphatase complex (dSTRIPAK) that 
dephoporylates Hpo, thereby reducing Hpo activity, and promoting Yki target gene expression [5]. We 
expected that the comislocalization of Hpo and dRASSF, in lgl
−/−
 tissue, could account for the 
decreased Hpo activity and increased Yki target gene expression observed [7]. However, in this study, 
we show that in the developing eye disc, dRASSF is not required to mislocalize Hpo in lgl mutant 
tissue. Furthermore, removal of dRASSF in GMR > aPKC
CA
 eye discs failed to reduce elevated levels 
of diap1 gene expression. These data indicate that the removal of dRASSF in lgl
−/−
 or GMR > aPKC
CA
 
tissue does not simply lead to the reestablishment of Hpo/Sav protein complexes and subsequent 
inhibition of Yki target gene expression.  
In this study we also demonstrated that the regulatory subunits of the dSTRIPAK complex, Cka and 
Mob4 colocalized with Hpo, and similar to Hpo, accumulated apically and Cka was mislocalized 
basolaterally in lgl
−/−
 tissue. Since dSTRIPAK is a negative regulator of Hpo, its accumulation with 
Hpo in lgl
−/−
 tissue might account for the decrease in Hpo activity. However, our data showing that 
depletion of members of the dSTRIPAK complex did not suppress the overgrown eye phenotype of 
GMR > aPKC
CA
, argues against this. This suggests that Lgl/aPKC regulate Hpo activity by a novel 
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mechanism, although it remains formally possible that dRASSF and dSTRIPAK act redundantly to 
inactivate Hpo, and that removal of both will be necessary to restore Hpo activity upon lgl 
depletion/aPKC
CA
 overexpression. Thus, the effect of Lgl/aPKC on the biochemical and functional 
interactions between dRASSF/dSTRIPAK/Hpo and Hpo/Sav protein complexes warrants further 
investigation. 
We observed a mild increase in tissue growth in lgl; dRASSF
−/−





adult eyes suggesting that dRASSF acts as a tumor suppressor when Lgl/aPKC activity is altered. Our 





compared to GMR > aPKC
CA
 eye discs, suggests that increased tissue growth is not due to further 
inactivation of the Hpo signalling pathway and upregulation of Yki target genes. This raises the 
possibility that dRASSF regulates additional growth signalling pathways. Consistent with previous 
data in mammalian and zebrafish systems, we observed an increase in MAPK signalling when the 
activity of aPKC cell polarity complexes was altered [24–26]. Although dRASSF has been previously 
linked to negative regulation of the Ras signalling pathway, we did not observe any change in pERK 




 tissue relative to GMR > aPKC
CA
, demonstrating 
that MAPK signalling is not altered by removal of dRASSF. Taken together our data clearly 
demonstrate that the molecular mechanisms utilized by dRASSF to regulate tissue growth, and the 
cellular contexts in which they are employed remain to be elucidated. The further exploration of the 
role of dRASSF in Drosophila development, and cancer models, should provide exciting insights into 
the complexities of cancer biology. 
Figure 5. Schematic model of Lgl/aPKC function in Hippo signalling. For simplicity, only 
proteins relevant to the current study are illustrated in the diagram. Interactions between 
different upstream components of the Hpo pathway and Yki are shown (positive interactions 
are illustrated by arrows, inhibitory interactions are depicted with blocked lines). The Hpo 
pathway controls tissue growth by regulating the subcellular localization of Yki, which 
when phosphorylated is cytoplasmic and unphosphorylated is nuclear. Yki associates with 
cognate transcription factors to promote cell proliferation and inhibit apoptosis. Lgl/aPKC 
regulate Hpo signalling independently of Fat/Dachs, Kibra/Expanded/Merlin and 
dRASSF/dSTRIPAK complexes. 
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Appendix 
Figure A1. Validation of cka-i. (A–C) Planar sections of larval eye discs. Yellow line 
indicates morphogenetic furrow. White scale bar represents 50 µM. (A,A') Control; GMR 
eye disc stained with F-actin and Cka revealing the apical surface of eye disc; (B,B') 
GMR/cka-i eye disc stained with F-actin and Cka, note apical depletion of Cka staining 
posterior to the morphogenetic furrow; (C,C') cka-i clones (GFP tissue) show depletion of 
Cka staining (white); (C",C''') overlay of GFP positive tissue and Cka staining confirms 
lack of Cka staining in clones expressing cka-i (pink), cka-i clone boundaries outlined with green 









, FRT40; tubgal4/+. 
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